Früherkennung und integrierte Versorgung von Jugendlichen und jungen Erwachsenen mit schweren psychotischen Erkrankungen

Zusammenfassung

Prospektive 1-Jahres-Follow-up-Untersuchung in der kombinierte multidimensionale Früherkennung und alters- und fachübergreifende integrierte Versorgung (Interventionsbedingung, n = 120) mit einer Standardbehandlung (historische Kontrollgruppe, n = 105) bei Jugendlichen und jungen Erwachsenen in der frühen Phase einer psychotischen Störung verglichen wird. Daten bei Aufnahme in die Studie weisen auf eine hohe Komplexität und Schwere der Erkrankung hin. Primäres Zielkriterium ist die Rate einer 6-monatigen kombiniert symptomatischen und funktionalen Remission zum Studienendpunkt.

Abstract

This is a prospective 1-year follow-up study comparing a combined intervention consisting of multidimensional early detection strategies with age- and interdisciplinary integrated care (intervention group, n = 120) with standard care (historical control group, n = 105) in adolescents and young adults within the early phase of psychosis. Data at study entry indicate a high complexity and severity of illness. Primary outcome is the 6-month rate of combined symptomatic and functional remission at study endpoint.

Schlüsselwörter

Psychosen - Früherkennung - integrierte Versorgung - Schizophrenie - bipolare Störung - psychenet

Keywords

early psychosis - early detection - integrated care - schizophrenia - bipolar disorder - psychenet

• Literatur

• 1 Delespaul PH. de consensusgroep EPA. Consensus regarding the definition of persons with severe mental illness and the number of such persons in the Netherlands. Tijdschr Psychiatr 2013; 55: 427-438
• 2 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Results from the 2012 National Survey on Drug Use and Health: Mental Health Findings. Im Internet: http://www.nimh.nih.gov/health/statistics/prevalence/serious-mental-illness-smi-among-us-adults.shtml (Stand: 1.10.2012)
• 3 Ruggeri M, Leese M, Thornicroft G et al. Definition and prevalence of severe and persistent mental illness. Br J Psychiatry 2000; 177: 149-155
• 4 Lambert M, Schöttle D, Ruppelt F et al. Integrierte Versorgung für erst- und mehrfacherkrankte Patienten mit schweren psychotischen Erkrankungen: 3-Jahres-Ergebnisse des Hamburger Modells. Bundesgesundheitsblatt DOI: 10.1007/s00103-015-2135-4.
• 5 Marshall M, Lewis S, Lockwood A et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975-983
• 6 Boonstra N, Klaassen R, Sytema S et al. Duration of untreated psychosis and negative symptoms – a systematic review and meta-analysis of individual patient data. Schizophr Res 2012; 142: 12-19
• 7 Penttilä M, Jääskeläinen E, Hirvonen N et al. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2014; 205: 88-94
• 8 Doyle R, Turner N, Fanning F et al. First-episode psychosis and disengagement from treatment: a systematic review. Psychiatr Serv 2014; 65: 603-611
• 9 Tiihonen J, Haukka J, Taylor M et al. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry 2011; 168: 603-609
• 10 Zipursky RB, Menezes NM, Streiner DL. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res 2014; 152: 408-414
• 11 Emsley R, Nuamah I, Hough D et al. Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia. Schizophr Res 2012; 138: 29-34
• 12 Wiersma D, Nienhuis FJ, Slooff CJ et al. Natural course of schizophrenic disorders: a 15-year follow up of a Dutch incidence cohort. Schizophr Bull 1998; 24: 75-85
• 13 Lloyd-Evans B, Crosby M, Stockton S et al. Initiatives to shorten duration of untreated psychosis: systematic review. Br J Psychiatry 2011; 198: 256-263
• 14 Menear M, Briand C. Implementing a continuum of evidence-based psychosocial interventions for people with severe mental illness: part 1-review of major initiatives and implementation strategies. Can J Psychiatry 2014; 59: 178-186
• 15 Briand C, Menear M. Implementing a continuum of evidence-based psychosocial interventions for people with severe mental illness: part 2-review of critical implementation issues. Can J Psychiatry 2014; 59: 187-195
• 16 Gühne U, Weinmann S, Arnold K et al. S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations. Eur Arch Psychiatry Clin Neurosci DOI: 10.1007/s00406-014-0558-9.
• 17 Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev 2011; 13 CD001089
• 18 Nordén T, Malm U, Norlander T. Resource Group Assertive Community Treatment (RACT) as a Tool of Empowerment for Clients with Severe Mental Illness: A Meta-Analysis. Clin Pract Epidemiol Ment Health 2012; 8: 144-151
• 19 Lambert M, Bock T, Schöttle D et al. Assertive Community Treatment (ACT) as part of Integrated Care versus Standard Care: a 12-month trial in patients with first- and negatively selected multiple-episode schizophrenia-spectrum disorders treated with quetiapine IR. J Clin Psychiatry 2010; 71: 1313-1323
• 20 Karow A, Reimer J, Schulz H et al. Cost-utility analysis of 12 months Assertive Community Treatment as part of Integrated Care versus Standard Care in patients with schizophrenia treated with Quetiapine (ACCESS Trial). J Clin Psychiatry 2012; 73: 402-408
• 21 Lambert M, Bock T, Daubmann A et al. The Hamburg-model of integrated care for patients with psychosis: Part 1. Rationale, treatment concept and results of the pre-study. Psychiat Prax 2014; 41: 257-265
• 22 Schöttle D, Bock T, Meigel-Schleiff C et al. Translating research into clinical practice: effectiveness of Integrated Care (IC) including therapeutic Assertive Community Treatment (ACT) in severe and persistent schizophrenia-spectrum and bipolar I disorders – a 24 months follow-up study (ACCESS II study). J Clin Psychiatry 2014; 75: 1371-1379
• 23 Karow A, Bock T, Daubmann A et al. The Hamburg-model of integrated care for patients with psychosis: Part 2. Results of the clinical course over 2- and 4-years of treatment. Psychiat Prax 2014; 41: 266-273
• 24 Härter M, Kentgens M, Brandes A et al. Rationale and content of psychenet: the Hamburg Network for Mental Health. Eur Arch Psychiatry Clin Neurosci 2012; 262 (Suppl. 02) 57-63
• 25 International Early Psychosis Association Writing Group. International clinical practice guidelines for early psychosis. Br J Psychiatry 2005; 187: 120-124
• 26 Andreasen NC, Carpenter Jr WT, Kane JM et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-449
• 27 Albert N, Bertelsen M, Thorup A et al. Predictors of recovery from psychosis Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res 2011; 125: 257-266
• 28 APA. Diagnostic & statistical manual of mental disorders. 4th. ed. Text Revision (DSM-IV-TR). Washington (DC): American Psychiatric Publishing; 2000
• 29 Lambert M, Karow A, Leucht S et al. Remission in schizophrenia: its validity, frequency, predictors and patients’ perspective 5 years after. Dialogues Clin Neurosci 2010; 12: 393-407